The effect of Empagliflozin on alleviating C4d over-activation in Diabetic kidney disease
Publication type: Journal Article
Publication date: 2025-05-01
scimago Q2
wos Q2
SJR: 0.671
CiteScore: 4.3
Impact factor: 1.8
ISSN: 00029629, 15382990
Abstract
BackgroundEmpagliflozin was associated with a slower progression of kidney disease. We aimed to investigate the effect of empagliflozin on alleviating complement over-activation in DKD.
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
1
|
|
|
Molecular and Cellular Biochemistry
1 publication, 100%
|
|
|
1
|
Publishers
|
1
|
|
|
Springer Nature
1 publication, 100%
|
|
|
1
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
1
Total citations:
1
Citations from 2024:
1
(100%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Fayed A. A. et al. The effect of Empagliflozin on alleviating C4d over-activation in Diabetic kidney disease // American Journal of the Medical Sciences. 2025. Vol. 369. No. 5. pp. 568-573.
GOST all authors (up to 50)
Copy
Fayed A. A., Fathy A., Rakha N. K., Soliman K. M., Hammad H. The effect of Empagliflozin on alleviating C4d over-activation in Diabetic kidney disease // American Journal of the Medical Sciences. 2025. Vol. 369. No. 5. pp. 568-573.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1016/j.amjms.2025.02.002
UR - https://linkinghub.elsevier.com/retrieve/pii/S0002962925009176
TI - The effect of Empagliflozin on alleviating C4d over-activation in Diabetic kidney disease
T2 - American Journal of the Medical Sciences
AU - Fayed, Ahmed Abdelaziz
AU - Fathy, Ahmed
AU - Rakha, Nehal Kamal
AU - Soliman, Karim M
AU - Hammad, Hany
PY - 2025
DA - 2025/05/01
PB - Elsevier
SP - 568-573
IS - 5
VL - 369
SN - 0002-9629
SN - 1538-2990
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2025_Fayed,
author = {Ahmed Abdelaziz Fayed and Ahmed Fathy and Nehal Kamal Rakha and Karim M Soliman and Hany Hammad},
title = {The effect of Empagliflozin on alleviating C4d over-activation in Diabetic kidney disease},
journal = {American Journal of the Medical Sciences},
year = {2025},
volume = {369},
publisher = {Elsevier},
month = {may},
url = {https://linkinghub.elsevier.com/retrieve/pii/S0002962925009176},
number = {5},
pages = {568--573},
doi = {10.1016/j.amjms.2025.02.002}
}
Cite this
MLA
Copy
Fayed, Ahmed Abdelaziz, et al. “The effect of Empagliflozin on alleviating C4d over-activation in Diabetic kidney disease.” American Journal of the Medical Sciences, vol. 369, no. 5, May. 2025, pp. 568-573. https://linkinghub.elsevier.com/retrieve/pii/S0002962925009176.